Announcements Trials
Browse Landscape

Phase

Phase NA 104Phase 4 12Phase 2 11Phase 3 9Phase 1 5Phase 2/3 3Phase EARLY_PHASE1 2Phase 1/2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 320Leukemia, Myeloid, Acute 266Multiple Myeloma 227Carcinoma, Non-Small-Cell Lung 224Prostatic Neoplasms 202Neoplasms 196Lymphoma 191Colorectal Neoplasms 184Melanoma 179Leukemia 170Recurrence 164Pancreatic Neoplasms 163Precursor Cell Lymphoblastic Leukemia-Lymphoma 160Lung Neoplasms 150Glioblastoma 134Neoplasm Metastasis 132Lymphoma, Non-Hodgkin 128Ovarian Neoplasms 123Leukemia, Lymphocytic, Chronic, B-Cell 120Myelodysplastic Syndromes 117Lymphoma, Large B-Cell, Diffuse 110Lymphoma, Mantle-Cell 108Carcinoma, Hepatocellular 103Lymphoma, Follicular 99Stomach Neoplasms 96Carcinoma, Renal Cell 89Hodgkin Disease 88Brain Neoplasms 88Sarcoma 84Burkitt Lymphoma 75

Interventions

Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Cancer Pain × Clear all
NCT03146806 2021-09-09

Intranasal (NAS) Ketamine for Cancer Pain

Emory University

Phase 1/2 Completed
10 enrolled 26 charts

Cancer Pain, Neoplasms, Pain

NCT00046709 2013-10-10

Marijuana for Cancer Pain

Center for Medicinal Cannabis Research

Phase 1/2 Terminated
16 enrolled

Cancer Pain, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡